Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2005, p. 794-797, Vol. 49, No. 2
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.2.794-797.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
School of Biotechnology and Biomolecular Sciences, Faculty of Science,2 School of Medical Sciences, Faculty of Medicine, the University of New South Wales,3 Virology Division, Department of Microbiology, SEALS, Prince of Wales Hospital, Randwick, Sydney, New South Wales, Australia1
Received 30 March 2004/ Returned for modification 26 June 2004/ Accepted 25 October 2004
|
|
|---|
|
|
|---|
Bacterial strains and antibiotic susceptibility testing. ESBL-producing Klebsiella spp. comprising 45 K. pneumoniae and 6 K. oxytoca from 20 different wards in three hospitals in Sydney, Australia, were collected from 1989 to 1999. Susceptibility to antimicrobial agents was determined by using the calibrated dichotomous sensitivity method (1), available at http://www.med.unsw.edu.au/pathology-cds/, to a panel of 20 antibiotics in seven different classes (Table 1). The diversity of the isolates was calculated by using Simpson's index with antibiotic profiles. The probability of selecting two strains with different profiles was 95.4%. All 51 isolates were resistant to ampicillin, cephalexin, and cefotaxime; 47.1% of bacteria were resistant to amikacin and trimethoprim, while 84.3% were resistant to kanamycin, 82.4% were resistant to tobramycin, and 72.5% were resistant to gentamicin (Table 1). All isolates tested were susceptible to cefotetan and imipenem. Multiresistant ESBL-producing bacteria, particularly those that are resistant to aminoglycosides, have been reported with increasing frequency (6, 7, 14, 22). From a therapeutic perspective, the varied scope of antibiotic resistance displayed by the isolates of this study highlights the difficulties faced by those treating infections with these bacteria.
|
View this table: [in a new window] |
TABLE 1. Resistance determinants and phenotypes of 51 ESBL-producing Klebsiella spp.a
|
![]() View larger version (13K): [in a new window] |
FIG. 1. Structure of two drug-resistant regions of pES1 isolated from Klebsiella oxytoca INS23K. Binding sites for primers used to screen the collection of 51 ESBL-producing Klebsiella spp. for integrase genes (primer pair hep35-hep36), class 1 cassette regions (primer pair hep58-hep59), IS26 (primer pair hep121-hep122), and blaSHV (primer pair A-B) are shown. The dashed line indicates the regions sequenced in this study; the lengths of those regions are shown. (A) The 5'-CS, aadB cassette, and 3'-CS were amplified by PCR with a combination of primers, and the products were sequenced. Analysis of the assembled 2,366-bp sequence revealed a class 1 integron with its associated intI1 gene (open box) and attI1 site (hatched box). The resistance genes identified, aadB (conferring resistance to gentamicin, tobramycin, and kanamycin), qacE 1, and sul1, are shown as thick black lines, and the aadB-associated 59-base element is shown as a filled box. The 2,366-bp nucleotide sequence differs by two nucleotides from the sequence of pDGO100 that contains integron In7 (GenBank accession number L06418; position 203 to 2,568). (B) The blaSHV-12 gene was amplified with primers A and B and sequenced. Sau3A fragments from pES1 were cloned into pUC18. pVRL98 was selected with cefotaxime and contained a 6-kb fragment of pES1. Approximately 1,400 bp of the 6-kb fragment were sequenced to revealed IS26 and the downstream blaSHV-12. IR indicates the position of the 14-bp terminal inverted repeats of IS26. The sequence matches that found in GenBank (accession number X84314; position 629 to 2,382), with the exception of a single point mutation that accounts for the difference between the SHV2a and SHV-12 enzymes at amino acid residue 240.
|
Horizontal transfer of the aadB gene cassette. The high incidence of the aadB gene cassette suggested that a common resistance element, which could also harbor a blaSHV gene, may be prevalent in the collection. To determine whether the integron carrying aadB was located on a transferable plasmid, transconjugation assays were performed on two strains, K. oxytoca INS22K and K. oxytoca INS23K, chosen on the basis of susceptibility to nalidixic acid. Conjugal transfer of kanamycin resistance was observed at average frequencies of between 3.8 x 107 and 6.1 x 106 transconjugants/donor. Antibiotic susceptibility testing of the transconjugants revealed phenotypic resistance to cephalexin, cefotaxime, ticarcillin-clavulanate potassium (Timentin), ampicillin, gentamicin, kanamycin, tobramycin, sulfonamide, trimethoprim, and nalidixic acid. Donor strains were additionally resistant to tetracycline, norfloxacin, chloramphenicol, and nitrofurantoin, indicating that the majority of the resistance genes were trans- ferred.
Plasmid extractions of the transconjugants isolated a plasmid (designated pES1) approximately 28 kb in size, while plasmid extractions of both donor strain INS22K and donor strain INS23K revealed the presence of pES1 and an additional plasmid (designated pES2) of approximately 4 kb in size (data not shown).
Resistance genes identified for pES1. PCR screening of pES1 extracted from transconjugants revealed a class 1 integron with an aadB gene cassette. The presence of both a 3' conserved segment (3'-CS) and a 5'-CS was confirmed by PCR amplification and sequencing (Fig. 1). Sulfonamide resistance was conferred by the presence of a sulfonamide resistance gene, sul1, found within the 3'-CS (20). The aadB gene cassette accounts for the gentamicin, kanamycin, and tobramycin resistance profile of the transconjugants. Transconjugants displayed ESBL activity by the characteristic "keyhole" interaction, in the form of a keyhole between cefotaxime and amoxicillin-clavulanate potassium (Augmentin), which was demonstrable by a disk diffusion susceptibility test (1). Transconjugants were screened by PCR for blaSHV genes as described above (14), and the products were sequenced. Sequencing revealed that pES1 harbored blaSHV-12. The presence of this gene accounts for the resistance to cephalexin, ampicillin, and cefotaxime seen in the transconjugants. Thus, a class 1 integron carrying aadB, sul1, and a blaSHV-12 gene was identified on pES1, and these genes together account for its multiple-resistance phenotype. Future research will focus on mapping the distance between aadB and blaSHV-12 and sequencing the intervening region. Our findings could help explain the recently reported nosocomial outbreak of multiresistant K. pneumoniae in The Netherlands (7), where 25 of 30 ESBL-producing bacteria (83.3%) were shown to carry blaSHV-5 and aadB. Consistent with our findings, eight strains also harbored aadA2 (7). The present study provides a possible explanation for the joint presence of aadB and blaSHV, colocated on a single transmissible plasmid in Klebsiella spp. The genetic determinant mediating trimethoprim resistance for pES1 was not identified.
blaSHV genes on transmissible plasmids are associated with integrons and IS26 elements. To isolate resistance genes carried on pES1, Sau3A fragments were cloned into pUC18 and transformants were selected on Luria-Bertani agar containing ampicillin (50 µg/ml) and subsequently selected on Luria-Bertani agar-cefotaxime (0.5 µg/ml) plates. This procedure led to the isolation of a plasmid, pVRL98, containing a fragment approximately 6 kb in size. Sequencing revealed a blaSHV-12 gene and an upstream insertion sequence, IS26 (Fig. 1). BLAST searches revealed that the fragment displayed identity to several plasmids from diverse locations worldwide (12, 13, 15, 17, 23). These plasmids all contain genes that encode for either SHV-2a or SHV-5 and that differ from SHV-12 (identified on pES1) by only one amino acid each, and all plasmids contain IS26. Moreover, class 1 integrons encoding aminoglycoside resistance have been reported for two of these plasmids (17, 23). The fact that IS26 is commonly found upstream of SHV-encoding genes suggests that it is involved in the creation of antibiotic resistance islands by promoting the integration of resistance genes (2, 8, 10).
Prevalence of IS26 and blaSHV in the ESBL-producing Klebsiella spp. Primers hep121 (5' AGCGGTAAATCGTGGAGTGA 3') and hep122 (5' TTGTCGCTTCTTTACTCGCC 3') were designed for a region 35 bp upstream of the blaSHV-12 gene and for a portion of the IS26 tnpA gene to determine the prevalence of this sequence in the collection of Klebsiella spp. (Fig. 1). PCR screening resulted in the amplification of a positive 250-bp product in 44 of 51 strains (86.2%). It is worthy to note that the seven IS26-negative strains were among the oldest in the collection, mostly dating from before 1991, and none harbored an integron. All 20 strains that harbored both aadA2 and aadB gene cassettes and all 13 strains with a single aadB cassette had a blaSHV gene with its associated upstream IS26 (Table 1), suggesting that these strains are likely to harbor a plasmid with features similar to those of pES1.
Conclusion. We and others (7) have demonstrated the close association of the aadB gene cassette with blaSHV genes in ESBL-producing Klebsiella, and in the present study, we show that both resistance genes are located on a single 28-kb conjugative plasmid. Our findings and those of others (12, 15-17, 23) also demonstrate that an IS26 insertion element upstream of a blaSHV gene is commonly associated with conjugative plasmids in ESBL-producing organisms. Klebsiella pneumoniae strains carrying IS26 upstream of blaSHV-12 or blaSHV-2a have also been recently reported in Korea (8). Taken together, these findings suggest that the multiresistant phenotype of ESBL-producing Klebsiella spp. is likely to be mediated by a conjugative plasmid that contains an integron, IS26, and either blaSHV-2a, blaSHV-5, or blaSHV-12. The potential of the integron-encoded site-specific recombination system to capture new cassettes means that continued selection of pES1-like plasmids is likely. Further studies concerning the evolution and dissemination of these plasmids are therefore warranted.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»